Chemify vs Pathos AI
Which Drug Discovery AI tool is better in 2026?
Chemify
Digitizing chemistry with AI and robotics to make any molecule on demand
Pathos AI
Patient-centric, AI-powered drug development company focused on accelerating cancer therapies
Side-by-side
Pathos AI is the more established option (raised $467M); pricing is comparable on both sides.
| Metric | Chemify | Pathos AI |
|---|---|---|
| Taglinei | Digitizing chemistry with AI and robotics to make any molecule on demand | Patient-centric, AI-powered drug development company focused on accelerating cancer therapies |
| Foundedi | 2022 | 2022 |
| HQi | Glasgow, United Kingdom | — |
| Employeesi | — | 11-50🏆 |
| Neuron scorei | 69🏆 | 57 |
| Total fundingi | $93M | $467M🏆 |
| Latest roundi | Series B · Oct 2025 | Series D · May 2025 |
| Valuationi | — | $1.6B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✓ |
| Free triali | ✗ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Enterprise · Contact sales | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Chemify and Pathos AI.
| Capability | Chemify | Pathos AI |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✓ |
| Free trial | ✗ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Chemify
- Higher Neuron score (69 vs 57)
🔵 Strengths of Pathos AI
- Has raised more capital ($467M vs $93M)
- Offers a free plan
- Offers a free trial
Which should you choose?
Choose Pathos AI if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Pathos AI if you want the most established option — it has raised $467M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Chemify vs Pathos AI — which is better?
It depends on your priority. Chemify is the leaner option; Pathos AI has broader feature depth. See the side-by-side table above.
Is Chemify cheaper than Pathos AI?
No — Pathos AI's cheapest paid plan is Free, while Chemify's is Enterprise · Contact sales.
Do Chemify and Pathos AI offer free plans?
Chemify: Paid only. Pathos AI: Yes, has a free plan.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.